VIVO Cannabis Inc. (TSXV: VIVO, OTCQX:
VVCIF) (“
VIVO” or the
“
Company”) is pleased to announce that it has
agreed to make a $5 million strategic investment in
National Access Cannabis Corp. (TSXV: META)
(“
NAC”), and commited to invest an additional $5
million contingent on attainment of a growth-related milestone and
the satisfaction of certain other conditions precedent. NAC intends
to use the proceeds of the investment, and additional recent and
proposed financings, to advance the roll out of its retail cannabis
operations across Canada. NAC’s vision is to be one of the largest
adult-use retailers in Canada, with over 200 locations providing
safe and responsible access to legal cannabis in Canadian private
retail markets, subject to licensing and regulatory approvals.
“VIVO sees great benefit in investing in and
establishing strong relationships with leading recreational retail
players in Canada, as represented by our two previously announced
strategic investments and partnerships in the sector earlier this
year. We believe that the retail side of the industry has great
potential and with our strong cash position, we chose to make
another strategic investment in a leading cannabis retailer,”
stated Barry Fishman, CEO of VIVO. “NAC’s retail brands (META
and Newleaf) are aligned with our philosophy of delivering top
quality products through a premium and engaged customer experience.
They are well-positioned to be a dominant player in the Canadian
retail landscape. VIVO looks forward to working with the NAC team
to provide Canadian adult-use consumers access to our premium
portfolio of brands, including FIRESIDE™, Lumina™ and Canna
Farms™.”
“The two main factors needed in creating growth
in the legal adult-use industry are convenient access and demanded
products,” stated Mark Goliger, CEO of NAC. “NAC will play a
dominant role in providing safe and responsible legal access points
across Canada, via an expected footprint of 200+ stores across five
private retail provinces. We are very happy to have an investor and
partner in VIVO who has developed premium quality products and
compelling brands. We trust that as an investor in NAC, VIVO will
impart some of the strategy, creativity and expertise that they put
into their consumer brands to enable enhanced market potential for
our retail store brands, META Cannabis Supply Co. and NewLeaf
Cannabis.”
VIVO Strategic Investment
VIVO has agreed to participate in private
placements of NAC common shares for an aggregate amount of up to
$10 million, which, subject to satisfaction of certain terms and
conditions precedent, will be completed in two tranches. Under the
initial tranche, VIVO has agreed to acquire NAC common shares for
an aggregate purchase price of $5 million. Closing of the initial
tranche is expected to occur on October 26, 2018.
If before October 26, 2019, NAC is granted
approval to open an aggregate of 50 cannabis retail locations from
applicable regulatory authorities in Canada, NAC may deliver a
written notice to VIVO requiring VIVO to purchase and subscribe for
$5 million of additional NAC common shares at a price per share
equal to the 15 day volume weighted average trading price of the
NAC common shares on the TSX Venture Exchange (the
“TSXV”) for the last 15 trading days of the
calendar month immediately preceding the date of the notice, or if
such trading price is lower than the maximum permitted discount for
the second tranche of the LP Financing, the maximum permitted
discount for the issuance of the Common Shares under TSXV
policies.
About VIVO Cannabis™
VIVO, based in Napanee, Ontario, is recognized
for trusted, high-quality products and services. It holds
production and sales licences from Health Canada and operates
world-class indoor cultivation facilities with proprietary
plant-growing technology. VIVO has a collection of premium brands
targeting unique customer segments, including Beacon Medical™,
FIRESIDE™, Canna Farms™ and Lumina™. In August 2018, VIVO
acquired Canna Farms Limited, a premium cannabis company based in
Hope, British Columbia. Canna Farms was B.C.’s first Licensed
Producer and has many years of craft cultivation experience and
expertise, as well as a significant patient base and positive cash
flow. VIVO is significantly expanding its production capacity and
pursuing partnership and product development opportunities
domestically, as well as in select international markets, including
Germany and Australia. In addition, VIVO also operates Harvest
Medicine, a patient-centric and highly scalable network of
specialty medical cannabis clinics. Harvest Medicine provides
best-in-class education and support to over 22,000 patients in its
clinics and via its free telemedicine platform. VIVO has a healthy
balance sheet and is well-positioned to accelerate the growth of
its business, in Canada and internationally.
About National Access
Cannabis
NAC is a best practices leader in
delivering secure, safe, and responsible access to legal cannabis
in Canada. Through its Canada-wide network of medical cannabis
clinics, partner pharmacies, NAC Bio's clinical research division,
NewLeaf Cannabis™ and Meta Cannabis Supply Co.™ recreational
cannabis retail stores, NAC enables patients and the public to gain
knowledge and access to Canada's network of authorized
Licensed Producers of cannabis. NAC is listed on the TSX Venture
Exchange under the symbol (TSXV: META).
ON BEHALF OF THE BOARD OF DIRECTORS
Barry Fishman (CEO and Director)
Neither TSX Venture Exchange nor its Regulation
Services Provider (as that term is defined in the policies of the
TSX Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
Disclaimer for Forward-Looking Statements
Statements regarding NAC’s business, proposed
use of proceeds of the financing and future goals are based solely
on information provided by NAC. This news release contains
forward-looking statements, including statements regarding the
expected timing of the closing of the initial tranche of the
financing, the proposed terms of VIVO’s second potential investment
in NAC common shares, the expected use of proceeds by NAC, NAC’s
proposed strategy to become a premium adult-use cannabis retailer
in Canada and its innovative retail concept, and VIVO’s future
opportunities outlook. The forward-looking statements contained in
this news release are based on certain assumptions and involve
known and unknown risks and uncertainties and other factors that
could cause actual events to differ materially from current
assumptions and expectations, including that: either or both of the
first investment and/or the second investment by VIVO in NAC common
shares may not be completed on the terms expected or at all; timing
of closing may not occur on the date expected, NAC may be unable to
obtain necessary regulatory approvals for the financing; NAC may
not be able to effectively operate a chain of cannabis retail
stores in Canada; NAC may not become a successful premium adult-use
cannabis retailer; regulations may restrict or prohibit the supply
of cannabis by VIVO to NAC; cannabis marketing regulations may
impede the execution of NAC’s retail strategy; and other factors
beyond the Company’s control. The forward-looking statements
contained in this news release should not be read as guarantees of
future performance or results. No assurance can be given that any
of the events anticipated by the forward-looking statements will
occur or, if they do occur, what benefits the Company will obtain
from them. Readers are urged to consider these factors, and the
more extensive risk factors included in the Company’s annual
information form dated April 30, 2018 and other continuous
disclosure filings, which are available on SEDAR
at www.sedar.com. Readers are cautioned not to place undue
reliance on these forward-looking statements, which are qualified
in their entirety by these cautionary statements. The
forward-looking statements in this news release are made as of the
date hereof and the Company disclaims any intent or obligation to
update publicly any such forward-looking statements, whether as a
result of new information, future events or results or otherwise,
except as required by applicable securities laws.
More Information on VIVO
Barry Fishman, CEO: barry.fishman@vivocannabis.com
Michael Bumby, CFO: michael.bumby@vivocannabis.com
Website: vivocannabis.com
More Information on NAC
Mark Goliger, CEO: info@nationalaccesscannabis.com
Website: www.nationalaccesscannabis.com
VIVO Cannabis (TSXV:VIVO)
Gráfica de Acción Histórica
De Dic 2024 a Ene 2025
VIVO Cannabis (TSXV:VIVO)
Gráfica de Acción Histórica
De Ene 2024 a Ene 2025